Connecticut cannabis lab designated to test for mold, E. coli contamination

State establishes pathogen-testing capacity as adult-use market expands past $713M in cumulative sales.

FILE — testing lab · NIST / public domain

Connecticut has designated a cannabis laboratory to conduct testing for mold and E. coli, according to reporting published September 26. The move suggests the state is moving to formalize microbial safety protocols as its adult-use market matures. Connecticut has generated $713M in cumulative sales since the 2023 launch and currently operates 78 retail licenses, 26 cultivation operations, and 13 manufacturers.

The lab designation appears to address a gap in the state's testing infrastructure: Connecticut's license roster shows zero operational testing facilities as of late September, despite 14 pending applications. Recent enforcement activity—including raids in Norwalk and Stratford that seized over 110 pounds of cannabis—underscores ongoing supply-chain compliance challenges that robust testing could help manage.

Watch for official release of testing protocols and whether the designated lab achieves operational status before year-end. The timing coincides with retail license churn (multiple operators cycling licenses in late September), suggesting quality standards may be tightening alongside market consolidation.